arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

MAXCYTE, INC.

MXCT

$1.17 ▲ +0.06 (+5.41%) at close

8 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

MAXCYTE, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $124.5M

Dividend Yield —

Revenue Growth -14.5% ↘

Op. Margin -157.1% ↘

ROIC -23.9% ↘

FCF / Share $-0.34 ↘

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$33.03M

↓ -14.5% —

Net Income Profit after all expenses

$-44.63M

↓ -8.7% —

Operating Margin Operating profit as % of sales

-157.1%

↓ -18.6% 1th

FCF / Share Free cash flow per share

$-0.34

↓ -21.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-14.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-390%)	-6.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-229%)	-6.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-234%)	30.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+512%)	29.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+490%)	21.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+321%)	—	—
EPS Growth YoY (%)	-7.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-5.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-60.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-23.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	26.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-60.9% Weak ↓ Weak Declining Year-over-year change in net income	-23.5% Weak ↑ Weak Improving Year-over-year change in net income	-61.5% Weak Weak Year-over-year change in net income	8.4% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	-21.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	-13.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	24.8% Good ↑ Good Improving Year-over-year change in free cash flow	-104.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	-2.5% Weak Weak Year-over-year change in free cash flow	12.5% Fair Fair Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-9.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	4.5% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	16.4% Excellent Excellent Compound annual revenue growth over 3 years	27.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	4.8% Fair Fair Compound annual revenue growth over 5 years	12.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-157.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1409%)	-132.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1205%)	-117.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1075%)	-61.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-615%)	-53.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-547%)	-42.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-452%)	-57.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-579%)	—
Profit Margin (%) (%)	-135.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1789%)	-106.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1429%)	-91.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1248%)	-53.3% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-766%)	-56.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-804%)	-45.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-664%)	-59.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-846%)	—
FCF Margin (%) (%)	-109.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-75.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-61.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-75.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-42.8% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-41.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-46.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-23.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-72.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-25.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-21.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-26.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-273%)	-19.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-16.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-9.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-7.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-35.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-337%)	-94.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-732%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	-3368.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-509.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	-239.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-20.07M	$-27.88M	$-46.51M	$-11.06M	$-47.78M	$-18.76M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.31	$0.37	$0.40	$0.44	$0.37	$0.38	$0.38	—
Basic EPS, GAAP (USD)	$-0.42	$-0.39	$-0.37	$-0.23	$-0.21	$-0.17	$-0.23	—
Free Cash Flow per Share (USD)	$-0.34	$-0.28	$-0.25	$-0.33	$-0.16	$-0.16	$-0.18	—
Book Value per Share (USD)	$1.61	$1.95	$2.23	$2.48	$2.60	$0.43	$0.24	—
Tangible Book Value per Share (USD)	$1.60	$1.95	$2.23	$2.48	$2.60	$0.43	$0.24	—
Basic Weighted Avg Shares (shares)	106.43M	104.85M	103.27M	101.70M	90.62M	69.46M	56.40M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$104.10M	$155.91M	$172.34M	$236.84M	$254.81M	$33.64M	—	—
Total Equity (USD)	$171.49M	$206.25M	$232.17M	$253.97M	$262.90M	$33.23M	$13.60M	$12.28M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$33.03M	$38.63M	$41.29M	$44.26M	$33.89M	$26.17M	$21.62M	—
Depreciation Expense (USD)	$4.34M	$4.32M	$4.17M	$2.70M	$1.42M	$1.05M	$613.50K	—
Net Income, GAAP (USD)	$-44.63M	$-41.05M	$-37.92M	$-23.57M	$-19.08M	$-11.82M	$-12.89M	—
Operating Cash Flow (USD)	$-34.41M	$-27.61M	$-21.69M	$-14.78M	$-10.68M	$-8.78M	$-8.80M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

MAXCYTE, INC.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MXCT with peers